A Multicenter, Phase I Study to Determine the Maximum Tolerated Dose, Safety, Pharmacokinetics and Efficacy of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma
Phase of Trial: Phase I
Latest Information Update: 05 Dec 2016
At a glance
- Drugs Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Adverse reactions
- 27 Jan 2011 Actual end date (December 2010) added as reported by ClinicalTrials.gov.
- 27 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jun 2008 Status changed from recruiting to in progress as reported by ClinicalTrials.gov.